MDxHealth

Foundation date

10/01/2003

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

MDxHealth is a molecular diagnostics company committed to developing novel, accurate, and informative diagnostic tests for early detection of cancer and for personalizing cancer treatment decisions.

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    1 day ago

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024